# OnCo record nct01906385 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01906385/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01906385", "NCT01906385" ;
  schema:name "Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)"@en ;
  schema:alternateName "ReSPECT"@en ;
  schema:description "A phase 1/2 trial of Rhenium Liposome Treatment in glioma & glioblastoma, run by Cerenome, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct01906385/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01906385> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2015-06-03" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:institutions <https://onco.cc/institutions/mays-cancer-center/> .